Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pre-Eclampsia | 46 | 2024 | 1256 | 5.340 |
Why?
|
Phthalic Acids | 34 | 2023 | 485 | 4.730 |
Why?
|
Maternal Exposure | 39 | 2024 | 1097 | 4.670 |
Why?
|
Environmental Pollutants | 34 | 2024 | 1294 | 3.760 |
Why?
|
Premature Birth | 40 | 2023 | 1830 | 3.760 |
Why?
|
Pregnancy | 221 | 2024 | 30235 | 3.060 |
Why?
|
Pregnancy Complications | 37 | 2024 | 2971 | 3.030 |
Why?
|
Fetal Development | 15 | 2024 | 777 | 2.610 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 14 | 2023 | 559 | 2.550 |
Why?
|
Phenols | 22 | 2024 | 526 | 2.400 |
Why?
|
Pregnancy Trimester, First | 24 | 2024 | 917 | 2.390 |
Why?
|
Fetal Growth Retardation | 15 | 2023 | 591 | 1.930 |
Why?
|
Pregnancy Trimester, Second | 15 | 2024 | 737 | 1.870 |
Why?
|
Obstetric Labor, Premature | 11 | 2020 | 268 | 1.820 |
Why?
|
Gestational Age | 45 | 2024 | 3617 | 1.700 |
Why?
|
Pregnancy Trimesters | 5 | 2019 | 197 | 1.690 |
Why?
|
Pregnancy Proteins | 8 | 2015 | 222 | 1.670 |
Why?
|
Birth Weight | 25 | 2024 | 2123 | 1.660 |
Why?
|
Cell-Derived Microparticles | 3 | 2020 | 159 | 1.650 |
Why?
|
Dinoprost | 10 | 2024 | 139 | 1.540 |
Why?
|
Fetal Membranes, Premature Rupture | 7 | 2023 | 137 | 1.530 |
Why?
|
Pregnancy Trimester, Third | 15 | 2023 | 587 | 1.290 |
Why?
|
Infant, Newborn | 90 | 2024 | 26388 | 1.170 |
Why?
|
Pregnancy Outcome | 28 | 2024 | 2970 | 1.170 |
Why?
|
Oxidative Stress | 17 | 2024 | 3141 | 1.160 |
Why?
|
Infant, Premature | 19 | 2019 | 2121 | 1.030 |
Why?
|
Anticonvulsants | 7 | 2022 | 1920 | 1.020 |
Why?
|
Benzhydryl Compounds | 10 | 2018 | 943 | 0.990 |
Why?
|
Placenta | 19 | 2023 | 1725 | 0.960 |
Why?
|
Endocrine Disruptors | 10 | 2024 | 264 | 0.950 |
Why?
|
Delivery, Obstetric | 13 | 2022 | 948 | 0.940 |
Why?
|
Maternal-Fetal Exchange | 4 | 2021 | 453 | 0.930 |
Why?
|
Glucose Intolerance | 4 | 2022 | 578 | 0.900 |
Why?
|
Eclampsia | 2 | 2022 | 61 | 0.870 |
Why?
|
Infant, Premature, Diseases | 7 | 2014 | 712 | 0.850 |
Why?
|
Nifedipine | 1 | 2023 | 220 | 0.850 |
Why?
|
Diabetes, Gestational | 9 | 2022 | 1263 | 0.840 |
Why?
|
Female | 226 | 2024 | 396354 | 0.840 |
Why?
|
Fetal Macrosomia | 4 | 2022 | 138 | 0.830 |
Why?
|
Cervix Uteri | 5 | 2020 | 575 | 0.820 |
Why?
|
Case-Control Studies | 45 | 2024 | 22245 | 0.820 |
Why?
|
Plasticizers | 5 | 2024 | 52 | 0.810 |
Why?
|
Deoxyguanosine | 5 | 2018 | 96 | 0.800 |
Why?
|
Fluorocarbons | 5 | 2024 | 498 | 0.740 |
Why?
|
Placenta Previa | 1 | 2023 | 125 | 0.730 |
Why?
|
Epilepsy | 8 | 2022 | 3317 | 0.730 |
Why?
|
Infant, Small for Gestational Age | 8 | 2022 | 468 | 0.730 |
Why?
|
Environmental Exposure | 12 | 2024 | 4544 | 0.730 |
Why?
|
Adult | 141 | 2024 | 223253 | 0.700 |
Why?
|
Phenol | 3 | 2023 | 45 | 0.680 |
Why?
|
Amniotic Fluid | 6 | 2012 | 381 | 0.680 |
Why?
|
Flame Retardants | 4 | 2024 | 97 | 0.680 |
Why?
|
Vitamin D | 12 | 2023 | 3270 | 0.670 |
Why?
|
Cesarean Section | 8 | 2022 | 1418 | 0.670 |
Why?
|
Pregnancy Complications, Infectious | 5 | 2021 | 2184 | 0.660 |
Why?
|
Thyroid Hormones | 5 | 2024 | 408 | 0.640 |
Why?
|
Placenta Accreta | 1 | 2023 | 242 | 0.630 |
Why?
|
Postpartum Period | 5 | 2024 | 1195 | 0.600 |
Why?
|
Humans | 231 | 2024 | 766432 | 0.590 |
Why?
|
Cerclage, Cervical | 4 | 2020 | 32 | 0.560 |
Why?
|
Vitamin D Deficiency | 6 | 2021 | 1348 | 0.530 |
Why?
|
Cervical Length Measurement | 1 | 2016 | 47 | 0.530 |
Why?
|
Inflammation | 13 | 2024 | 10860 | 0.520 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 2 | 2014 | 59 | 0.520 |
Why?
|
Prenatal Exposure Delayed Effects | 9 | 2024 | 2538 | 0.520 |
Why?
|
Young Adult | 58 | 2024 | 59928 | 0.520 |
Why?
|
Weight Gain | 5 | 2023 | 2356 | 0.510 |
Why?
|
Body Mass Index | 16 | 2020 | 13045 | 0.500 |
Why?
|
Reproductive Techniques, Assisted | 2 | 2018 | 503 | 0.500 |
Why?
|
Thyroid Diseases | 2 | 2018 | 385 | 0.500 |
Why?
|
Vitamins | 6 | 2023 | 1630 | 0.490 |
Why?
|
Cytokines | 10 | 2024 | 7436 | 0.480 |
Why?
|
Metals | 4 | 2019 | 711 | 0.470 |
Why?
|
Twins | 2 | 2010 | 341 | 0.470 |
Why?
|
Respiratory Distress Syndrome, Newborn | 3 | 2006 | 239 | 0.470 |
Why?
|
Matrix Metalloproteinases | 4 | 2017 | 391 | 0.460 |
Why?
|
Episiotomy | 3 | 2011 | 21 | 0.460 |
Why?
|
Maternal Age | 7 | 2020 | 804 | 0.440 |
Why?
|
Piracetam | 1 | 2014 | 88 | 0.440 |
Why?
|
Uterine Cervical Incompetence | 2 | 2010 | 24 | 0.440 |
Why?
|
Angiogenesis Inducing Agents | 2 | 2012 | 253 | 0.440 |
Why?
|
Prospective Studies | 36 | 2024 | 54826 | 0.430 |
Why?
|
Psychoses, Substance-Induced | 1 | 2014 | 98 | 0.430 |
Why?
|
Fetal Viability | 2 | 2004 | 23 | 0.430 |
Why?
|
Ultrasonography, Prenatal | 8 | 2022 | 1772 | 0.430 |
Why?
|
Hysterectomy | 2 | 2018 | 863 | 0.430 |
Why?
|
Logistic Models | 23 | 2021 | 13276 | 0.430 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 161 | 0.430 |
Why?
|
Obstetric Labor Complications | 5 | 2019 | 240 | 0.420 |
Why?
|
Chorioamnionitis | 4 | 2011 | 154 | 0.420 |
Why?
|
Boston | 21 | 2024 | 9333 | 0.420 |
Why?
|
Blood Glucose | 7 | 2024 | 6422 | 0.410 |
Why?
|
Oxylipins | 2 | 2024 | 54 | 0.410 |
Why?
|
Interleukin-10 | 2 | 2024 | 1182 | 0.400 |
Why?
|
Obesity | 13 | 2024 | 13088 | 0.400 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2012 | 52 | 0.390 |
Why?
|
RNA | 1 | 2022 | 2715 | 0.390 |
Why?
|
Magnesium Sulfate | 2 | 2020 | 73 | 0.380 |
Why?
|
Odds Ratio | 18 | 2022 | 9654 | 0.380 |
Why?
|
Pregnant Women | 7 | 2023 | 576 | 0.370 |
Why?
|
Thyroid Gland | 1 | 2018 | 1170 | 0.370 |
Why?
|
Dystocia | 1 | 2011 | 33 | 0.370 |
Why?
|
Bronchopulmonary Dysplasia | 2 | 2016 | 329 | 0.350 |
Why?
|
Linear Models | 10 | 2022 | 5872 | 0.340 |
Why?
|
Pregnancy, Multiple | 2 | 2010 | 216 | 0.340 |
Why?
|
Hypertension | 5 | 2023 | 8614 | 0.330 |
Why?
|
Chemokines | 4 | 2020 | 962 | 0.330 |
Why?
|
Birth Injuries | 1 | 2011 | 150 | 0.330 |
Why?
|
Microcephaly | 2 | 2010 | 427 | 0.320 |
Why?
|
Brachial Plexus | 1 | 2011 | 171 | 0.320 |
Why?
|
Infant Mortality | 6 | 2019 | 752 | 0.320 |
Why?
|
Urinary Tract Infections | 1 | 2015 | 804 | 0.320 |
Why?
|
Placenta Diseases | 3 | 2012 | 199 | 0.310 |
Why?
|
Birth Order | 2 | 2019 | 93 | 0.310 |
Why?
|
Hypertension, Pregnancy-Induced | 4 | 2016 | 530 | 0.310 |
Why?
|
Inflammation Mediators | 3 | 2019 | 1889 | 0.310 |
Why?
|
Cerebral Palsy | 2 | 2012 | 481 | 0.310 |
Why?
|
Abnormalities, Drug-Induced | 3 | 2019 | 337 | 0.300 |
Why?
|
Eicosanoids | 2 | 2020 | 284 | 0.300 |
Why?
|
Leukomalacia, Periventricular | 1 | 2009 | 184 | 0.300 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2013 | 621 | 0.300 |
Why?
|
Abortion, Spontaneous | 4 | 2024 | 536 | 0.300 |
Why?
|
Multiple Sclerosis | 6 | 2024 | 3229 | 0.290 |
Why?
|
Interleukin-6 | 2 | 2024 | 3226 | 0.290 |
Why?
|
Cohort Studies | 35 | 2024 | 41703 | 0.290 |
Why?
|
Progesterone | 2 | 2023 | 752 | 0.280 |
Why?
|
Proteinuria | 1 | 2010 | 613 | 0.280 |
Why?
|
Risk Factors | 36 | 2024 | 74828 | 0.280 |
Why?
|
Alkanesulfonic Acids | 3 | 2024 | 198 | 0.280 |
Why?
|
Mass Spectrometry | 3 | 2020 | 2196 | 0.280 |
Why?
|
Puerperal Disorders | 2 | 2022 | 304 | 0.280 |
Why?
|
Sensitivity and Specificity | 9 | 2022 | 14643 | 0.270 |
Why?
|
Infant, Newborn, Diseases | 2 | 2022 | 587 | 0.270 |
Why?
|
Asthma | 6 | 2023 | 6267 | 0.260 |
Why?
|
Cell Adhesion Molecules | 3 | 2011 | 1612 | 0.260 |
Why?
|
Parabens | 4 | 2019 | 117 | 0.250 |
Why?
|
Glucose Tolerance Test | 5 | 2024 | 1180 | 0.250 |
Why?
|
Dietary Supplements | 4 | 2024 | 3428 | 0.240 |
Why?
|
Neovascularization, Physiologic | 4 | 2019 | 1366 | 0.240 |
Why?
|
Multivariate Analysis | 8 | 2019 | 12061 | 0.240 |
Why?
|
Creatinine | 1 | 2010 | 1916 | 0.230 |
Why?
|
Fetal Organ Maturity | 2 | 2004 | 83 | 0.230 |
Why?
|
F2-Isoprostanes | 1 | 2024 | 35 | 0.230 |
Why?
|
Immunologic Factors | 2 | 2024 | 1594 | 0.230 |
Why?
|
Fetus | 5 | 2023 | 1878 | 0.230 |
Why?
|
Models, Theoretical | 1 | 2016 | 3562 | 0.220 |
Why?
|
Chromatography, Liquid | 2 | 2019 | 996 | 0.220 |
Why?
|
Alanine Transaminase | 2 | 2016 | 608 | 0.210 |
Why?
|
Rh-Hr Blood-Group System | 1 | 2023 | 64 | 0.210 |
Why?
|
Pulmonary Surfactants | 1 | 2004 | 169 | 0.210 |
Why?
|
Tocolytic Agents | 1 | 2003 | 24 | 0.210 |
Why?
|
Head | 3 | 2017 | 926 | 0.210 |
Why?
|
Trophoblasts | 2 | 2018 | 223 | 0.210 |
Why?
|
Perineum | 3 | 2017 | 212 | 0.210 |
Why?
|
Estradiol | 3 | 2020 | 1947 | 0.200 |
Why?
|
Esters | 4 | 2024 | 212 | 0.200 |
Why?
|
Parity | 6 | 2016 | 931 | 0.200 |
Why?
|
Metabolome | 2 | 2020 | 1009 | 0.200 |
Why?
|
Depression | 2 | 2019 | 8229 | 0.200 |
Why?
|
Blood Proteins | 3 | 2013 | 1192 | 0.200 |
Why?
|
Blood Group Antigens | 1 | 2023 | 183 | 0.190 |
Why?
|
Perinatology | 1 | 2002 | 64 | 0.190 |
Why?
|
Prenatal Care | 4 | 2023 | 1158 | 0.190 |
Why?
|
Enalapril | 1 | 2023 | 317 | 0.190 |
Why?
|
Environmental Monitoring | 5 | 2019 | 1467 | 0.190 |
Why?
|
Insulin-Like Growth Factor II | 2 | 2014 | 271 | 0.190 |
Why?
|
Blood Pressure | 4 | 2024 | 8532 | 0.190 |
Why?
|
ROC Curve | 3 | 2016 | 3616 | 0.180 |
Why?
|
Albumins | 1 | 2004 | 578 | 0.180 |
Why?
|
Micronutrients | 1 | 2024 | 390 | 0.180 |
Why?
|
Models, Statistical | 4 | 2019 | 5089 | 0.180 |
Why?
|
Infant, Extremely Low Birth Weight | 2 | 2012 | 83 | 0.180 |
Why?
|
Obstetric Surgical Procedures | 1 | 2000 | 31 | 0.180 |
Why?
|
Consumer Product Safety | 1 | 2021 | 122 | 0.180 |
Why?
|
Trace Elements | 2 | 2019 | 193 | 0.170 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2016 | 1528 | 0.170 |
Why?
|
Thyroxine | 3 | 2018 | 665 | 0.170 |
Why?
|
Cosmetics | 1 | 2021 | 104 | 0.170 |
Why?
|
Fetal Blood | 6 | 2023 | 1366 | 0.170 |
Why?
|
Infertility, Female | 2 | 2013 | 763 | 0.170 |
Why?
|
Acidosis | 1 | 2021 | 271 | 0.160 |
Why?
|
Hydatidiform Mole | 1 | 2022 | 255 | 0.160 |
Why?
|
Male | 45 | 2024 | 363975 | 0.160 |
Why?
|
Laparoscopy | 3 | 2020 | 2039 | 0.160 |
Why?
|
Analgesia, Epidural | 2 | 2019 | 332 | 0.160 |
Why?
|
United States | 20 | 2024 | 72910 | 0.160 |
Why?
|
Placentation | 1 | 2019 | 78 | 0.160 |
Why?
|
Alpha-Globulins | 1 | 2019 | 26 | 0.160 |
Why?
|
Proteinase Inhibitory Proteins, Secretory | 1 | 2019 | 49 | 0.160 |
Why?
|
Factor XIII | 1 | 2019 | 59 | 0.160 |
Why?
|
Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2019 | 33 | 0.160 |
Why?
|
Paternal Exposure | 1 | 2019 | 100 | 0.160 |
Why?
|
Estrone | 1 | 2020 | 234 | 0.160 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2016 | 518 | 0.160 |
Why?
|
Regression Analysis | 5 | 2019 | 6327 | 0.160 |
Why?
|
Amine Oxidase (Copper-Containing) | 1 | 2018 | 41 | 0.150 |
Why?
|
Angiogenic Proteins | 1 | 2018 | 101 | 0.150 |
Why?
|
Preconception Care | 1 | 2019 | 143 | 0.150 |
Why?
|
Reference Values | 7 | 2018 | 4913 | 0.150 |
Why?
|
Carbanilides | 1 | 2018 | 18 | 0.150 |
Why?
|
Predictive Value of Tests | 7 | 2022 | 15390 | 0.150 |
Why?
|
Retrospective Studies | 17 | 2023 | 81588 | 0.150 |
Why?
|
Benzophenones | 1 | 2018 | 58 | 0.150 |
Why?
|
Analgesia, Obstetrical | 1 | 2019 | 169 | 0.150 |
Why?
|
Isotretinoin | 1 | 2019 | 135 | 0.150 |
Why?
|
Prolactin | 1 | 2020 | 627 | 0.150 |
Why?
|
Infant, Very Low Birth Weight | 2 | 2016 | 409 | 0.140 |
Why?
|
Labor Presentation | 1 | 2017 | 54 | 0.140 |
Why?
|
Labor Stage, Second | 1 | 2017 | 45 | 0.140 |
Why?
|
Brain Diseases | 2 | 2003 | 1552 | 0.140 |
Why?
|
Thyroid Function Tests | 1 | 2018 | 289 | 0.140 |
Why?
|
Magnesium | 1 | 2020 | 815 | 0.140 |
Why?
|
Longitudinal Studies | 10 | 2020 | 14760 | 0.130 |
Why?
|
Body Size | 1 | 2019 | 461 | 0.130 |
Why?
|
Massachusetts | 8 | 2023 | 8885 | 0.130 |
Why?
|
Risk Assessment | 10 | 2019 | 24272 | 0.130 |
Why?
|
Cross-Sectional Studies | 9 | 2021 | 26294 | 0.130 |
Why?
|
Tretinoin | 1 | 2019 | 524 | 0.130 |
Why?
|
Adolescent | 19 | 2023 | 88898 | 0.130 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2024 | 4348 | 0.130 |
Why?
|
Antioxidants | 1 | 2024 | 1671 | 0.130 |
Why?
|
Likelihood Functions | 1 | 2019 | 993 | 0.130 |
Why?
|
Suture Techniques | 1 | 2000 | 775 | 0.120 |
Why?
|
Fatty Acids | 1 | 2023 | 1807 | 0.120 |
Why?
|
Insurance Claim Review | 2 | 2018 | 744 | 0.120 |
Why?
|
Incidence | 11 | 2020 | 21509 | 0.120 |
Why?
|
Lead | 1 | 2021 | 878 | 0.120 |
Why?
|
Area Under Curve | 1 | 2019 | 1638 | 0.120 |
Why?
|
Live Birth | 1 | 2019 | 516 | 0.120 |
Why?
|
Socioeconomic Factors | 6 | 2019 | 7840 | 0.120 |
Why?
|
Infant | 15 | 2024 | 36460 | 0.120 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 587 | 0.120 |
Why?
|
Healthcare Disparities | 1 | 2010 | 3403 | 0.120 |
Why?
|
Risk | 4 | 2017 | 9601 | 0.120 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2019 | 463 | 0.120 |
Why?
|
Mongolia | 3 | 2020 | 93 | 0.120 |
Why?
|
Proteomics | 2 | 2020 | 3906 | 0.120 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2021 | 1354 | 0.120 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39283 | 0.120 |
Why?
|
Demography | 1 | 2019 | 1641 | 0.110 |
Why?
|
Calcium-Binding Proteins | 1 | 2019 | 1077 | 0.110 |
Why?
|
Blood Chemical Analysis | 1 | 2016 | 434 | 0.110 |
Why?
|
Hazardous Substances | 1 | 2015 | 153 | 0.110 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2014 | 83 | 0.110 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2029 | 0.110 |
Why?
|
Breast Feeding | 1 | 2022 | 1363 | 0.110 |
Why?
|
Interleukin-1beta | 1 | 2019 | 1026 | 0.110 |
Why?
|
Prenatal Diagnosis | 3 | 2023 | 1271 | 0.110 |
Why?
|
Lung | 2 | 2004 | 10064 | 0.110 |
Why?
|
Thyrotropin | 1 | 2017 | 834 | 0.110 |
Why?
|
Coitus | 1 | 2014 | 132 | 0.110 |
Why?
|
Retinopathy of Prematurity | 2 | 2013 | 449 | 0.110 |
Why?
|
C-Reactive Protein | 4 | 2024 | 3852 | 0.100 |
Why?
|
Uterine Neoplasms | 1 | 2022 | 1424 | 0.100 |
Why?
|
Time Factors | 6 | 2019 | 40116 | 0.100 |
Why?
|
HELLP Syndrome | 1 | 2012 | 41 | 0.100 |
Why?
|
Genomic Imprinting | 1 | 2014 | 326 | 0.100 |
Why?
|
Brain Injury, Chronic | 1 | 2012 | 68 | 0.100 |
Why?
|
Fever | 1 | 2019 | 1607 | 0.100 |
Why?
|
Estrogens | 1 | 2019 | 1528 | 0.100 |
Why?
|
Immunization | 1 | 2016 | 1218 | 0.100 |
Why?
|
Smoking | 4 | 2015 | 9076 | 0.100 |
Why?
|
Respiratory Sounds | 1 | 2016 | 702 | 0.090 |
Why?
|
Organ Size | 1 | 2016 | 2261 | 0.090 |
Why?
|
Hyperoxia | 1 | 2013 | 259 | 0.090 |
Why?
|
Cholecalciferol | 1 | 2016 | 550 | 0.090 |
Why?
|
Propensity Score | 1 | 2018 | 1972 | 0.090 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12527 | 0.090 |
Why?
|
Abortion, Habitual | 1 | 2010 | 65 | 0.090 |
Why?
|
Decidua | 2 | 2022 | 80 | 0.080 |
Why?
|
Heart Rate, Fetal | 1 | 2010 | 77 | 0.080 |
Why?
|
Child Behavior Disorders | 1 | 2014 | 812 | 0.080 |
Why?
|
Folic Acid | 3 | 2023 | 1337 | 0.080 |
Why?
|
Air Pollution | 1 | 2023 | 2379 | 0.080 |
Why?
|
Postnatal Care | 2 | 2014 | 273 | 0.080 |
Why?
|
Particulate Matter | 1 | 2021 | 2623 | 0.080 |
Why?
|
Probability | 2 | 2022 | 2475 | 0.080 |
Why?
|
Reproductive History | 1 | 2010 | 210 | 0.080 |
Why?
|
Bayes Theorem | 3 | 2023 | 2352 | 0.080 |
Why?
|
Mental Recall | 1 | 2015 | 1218 | 0.080 |
Why?
|
Cephalometry | 1 | 2010 | 380 | 0.080 |
Why?
|
Urban Population | 1 | 2016 | 2038 | 0.080 |
Why?
|
Puerto Rico | 2 | 2019 | 380 | 0.070 |
Why?
|
Fetal Diseases | 1 | 2013 | 915 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2020 | 3446 | 0.070 |
Why?
|
Attitude of Health Personnel | 1 | 2002 | 3928 | 0.070 |
Why?
|
Vaccines | 1 | 2016 | 842 | 0.070 |
Why?
|
Labor, Obstetric | 2 | 2017 | 313 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 18075 | 0.070 |
Why?
|
Gonadal Steroid Hormones | 1 | 2011 | 706 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2844 | 0.070 |
Why?
|
Analysis of Variance | 1 | 2016 | 6212 | 0.070 |
Why?
|
Child Development | 3 | 2022 | 2327 | 0.070 |
Why?
|
Air Pollutants | 1 | 2021 | 2921 | 0.070 |
Why?
|
Parturition | 2 | 2023 | 453 | 0.070 |
Why?
|
Angiotensin II | 1 | 2010 | 844 | 0.070 |
Why?
|
Fertilization in Vitro | 1 | 2015 | 1301 | 0.070 |
Why?
|
Cerebral Ventricles | 1 | 2009 | 550 | 0.070 |
Why?
|
Sleep Deprivation | 1 | 2014 | 848 | 0.070 |
Why?
|
Comorbidity | 3 | 2021 | 10579 | 0.070 |
Why?
|
Body Weight | 1 | 2017 | 4625 | 0.070 |
Why?
|
Maternal-Child Health Centers | 1 | 2006 | 41 | 0.070 |
Why?
|
Hemostasis, Surgical | 1 | 2007 | 128 | 0.070 |
Why?
|
Uterus | 2 | 2018 | 660 | 0.070 |
Why?
|
Middle Aged | 12 | 2019 | 223127 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4215 | 0.060 |
Why?
|
Bacteremia | 1 | 2013 | 987 | 0.060 |
Why?
|
Morbidity | 2 | 2021 | 1753 | 0.060 |
Why?
|
Rural Population | 1 | 2016 | 2317 | 0.060 |
Why?
|
Triiodothyronine | 2 | 2018 | 493 | 0.060 |
Why?
|
Sulfones | 2 | 2018 | 447 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2815 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16721 | 0.060 |
Why?
|
Malpractice | 1 | 2010 | 561 | 0.060 |
Why?
|
Steroids | 2 | 2018 | 936 | 0.060 |
Why?
|
Factor V | 1 | 2005 | 168 | 0.060 |
Why?
|
Diethylhexyl Phthalate | 2 | 2016 | 86 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2023 | 65202 | 0.060 |
Why?
|
DNA | 1 | 2018 | 7207 | 0.060 |
Why?
|
Isoprostanes | 1 | 2024 | 21 | 0.060 |
Why?
|
Cluster Analysis | 1 | 2011 | 2718 | 0.060 |
Why?
|
Blood Vessels | 1 | 2010 | 1111 | 0.060 |
Why?
|
Antigens, CD | 1 | 2014 | 4031 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2019 | 4527 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3458 | 0.060 |
Why?
|
Polypyrimidine Tract-Binding Protein | 1 | 2023 | 22 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9521 | 0.060 |
Why?
|
Fluorescence Polarization | 1 | 2004 | 139 | 0.050 |
Why?
|
Research Design | 1 | 2019 | 6205 | 0.050 |
Why?
|
Computational Biology | 1 | 2016 | 3564 | 0.050 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2005 | 184 | 0.050 |
Why?
|
Administration, Intravaginal | 1 | 2023 | 149 | 0.050 |
Why?
|
Infant, Low Birth Weight | 1 | 2008 | 870 | 0.050 |
Why?
|
Ultrasonography | 2 | 2009 | 5988 | 0.050 |
Why?
|
Leptin | 1 | 2011 | 1596 | 0.050 |
Why?
|
Anesthesia, Obstetrical | 1 | 2005 | 234 | 0.050 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15897 | 0.050 |
Why?
|
Developmental Disabilities | 1 | 2012 | 1519 | 0.050 |
Why?
|
Practice Guidelines as Topic | 3 | 2016 | 7426 | 0.050 |
Why?
|
Prognosis | 3 | 2021 | 29922 | 0.050 |
Why?
|
Feeding Behavior | 2 | 2014 | 3208 | 0.050 |
Why?
|
Europe | 2 | 2020 | 3427 | 0.050 |
Why?
|
Genome-Wide Association Study | 2 | 2020 | 12807 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 16042 | 0.050 |
Why?
|
Arachidonic Acid | 1 | 2024 | 430 | 0.050 |
Why?
|
Models, Biological | 1 | 2018 | 9458 | 0.050 |
Why?
|
Fetal Weight | 1 | 2022 | 90 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2024 | 12423 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2020 | 21157 | 0.050 |
Why?
|
Progestins | 1 | 2023 | 300 | 0.050 |
Why?
|
Limit of Detection | 1 | 2022 | 271 | 0.050 |
Why?
|
Nutritional Status | 2 | 2019 | 1621 | 0.050 |
Why?
|
Beta Particles | 1 | 2021 | 52 | 0.050 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2024 | 539 | 0.040 |
Why?
|
Algorithms | 2 | 2016 | 14071 | 0.040 |
Why?
|
Point Mutation | 1 | 2005 | 1591 | 0.040 |
Why?
|
Prevalence | 4 | 2019 | 15820 | 0.040 |
Why?
|
Hospitalization | 2 | 2021 | 10812 | 0.040 |
Why?
|
Extraction, Obstetrical | 1 | 2020 | 28 | 0.040 |
Why?
|
Sphingomyelins | 1 | 2000 | 104 | 0.040 |
Why?
|
Lactation | 1 | 2022 | 392 | 0.040 |
Why?
|
Phosphates | 1 | 2023 | 763 | 0.040 |
Why?
|
Insulin Resistance | 2 | 2016 | 3989 | 0.040 |
Why?
|
Guidelines as Topic | 2 | 2016 | 1394 | 0.040 |
Why?
|
Radiography, Interventional | 1 | 2007 | 1127 | 0.040 |
Why?
|
Pilot Projects | 3 | 2021 | 8720 | 0.040 |
Why?
|
Nervous System Diseases | 1 | 2010 | 1659 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3788 | 0.040 |
Why?
|
Child, Preschool | 7 | 2019 | 42576 | 0.040 |
Why?
|
Vasculitis | 1 | 2003 | 528 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 3724 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2013 | 2432 | 0.040 |
Why?
|
Pregnancy, Unplanned | 1 | 2019 | 85 | 0.040 |
Why?
|
Nerve Block | 1 | 2005 | 717 | 0.040 |
Why?
|
Maternal Mortality | 1 | 2021 | 310 | 0.040 |
Why?
|
Nutritional Requirements | 1 | 2000 | 276 | 0.040 |
Why?
|
Phosphatidylcholines | 1 | 2000 | 404 | 0.040 |
Why?
|
Pregnancy in Adolescence | 1 | 2000 | 164 | 0.040 |
Why?
|
Tetanus | 1 | 1998 | 52 | 0.040 |
Why?
|
Diseases in Twins | 1 | 2000 | 447 | 0.040 |
Why?
|
Oxygen | 1 | 2010 | 4251 | 0.040 |
Why?
|
Michigan | 1 | 2019 | 329 | 0.040 |
Why?
|
Naphthalenesulfonates | 1 | 2017 | 17 | 0.040 |
Why?
|
Glycogen | 1 | 2018 | 252 | 0.040 |
Why?
|
Registries | 3 | 2019 | 8344 | 0.040 |
Why?
|
Tetanus Toxoid | 1 | 1998 | 188 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2012 | 3967 | 0.040 |
Why?
|
Immunity, Maternally-Acquired | 1 | 1998 | 112 | 0.040 |
Why?
|
Intracranial Hemorrhages | 1 | 2003 | 810 | 0.040 |
Why?
|
Lipid Peroxidation | 1 | 2018 | 275 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2014 | 4418 | 0.040 |
Why?
|
Triclosan | 1 | 2018 | 59 | 0.040 |
Why?
|
California | 1 | 2021 | 1435 | 0.040 |
Why?
|
Norway | 1 | 2018 | 500 | 0.040 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2017 | 147 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2011 | 660 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2015 | 15639 | 0.030 |
Why?
|
Anti-HIV Agents | 1 | 2013 | 4561 | 0.030 |
Why?
|
Interferon-beta | 1 | 2019 | 348 | 0.030 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2001 | 328 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2021 | 2477 | 0.030 |
Why?
|
Data Interpretation, Statistical | 2 | 2018 | 2693 | 0.030 |
Why?
|
Israel | 1 | 2019 | 722 | 0.030 |
Why?
|
Genotype | 2 | 2023 | 13034 | 0.030 |
Why?
|
Lactic Acid | 1 | 2021 | 1137 | 0.030 |
Why?
|
Patient Compliance | 1 | 2006 | 2694 | 0.030 |
Why?
|
Pregnancy Rate | 1 | 2019 | 654 | 0.030 |
Why?
|
Minority Groups | 1 | 2023 | 1208 | 0.030 |
Why?
|
Cleft Lip | 1 | 2001 | 512 | 0.030 |
Why?
|
Telomere | 1 | 2022 | 941 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5883 | 0.030 |
Why?
|
Child | 6 | 2022 | 80668 | 0.030 |
Why?
|
Parents | 2 | 2023 | 3595 | 0.030 |
Why?
|
Nitrogen Dioxide | 1 | 2019 | 538 | 0.030 |
Why?
|
HIV-1 | 1 | 2013 | 6948 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2016 | 570 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2012 | 7866 | 0.030 |
Why?
|
DNA Methylation | 2 | 2023 | 4428 | 0.030 |
Why?
|
Research Support as Topic | 1 | 2019 | 697 | 0.030 |
Why?
|
Aspartic Acid | 1 | 2017 | 575 | 0.030 |
Why?
|
Carbon | 1 | 2018 | 673 | 0.030 |
Why?
|
Recurrence | 2 | 2019 | 8478 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2021 | 1308 | 0.030 |
Why?
|
Neurotransmitter Agents | 1 | 2018 | 661 | 0.030 |
Why?
|
Nuclear Family | 1 | 2015 | 311 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2017 | 633 | 0.030 |
Why?
|
Databases, Factual | 3 | 2019 | 8061 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 800 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2016 | 957 | 0.030 |
Why?
|
Hormones | 1 | 2018 | 866 | 0.030 |
Why?
|
Veins | 1 | 2018 | 770 | 0.030 |
Why?
|
Lymphatic Vessels | 1 | 2018 | 356 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2010 | 4712 | 0.030 |
Why?
|
Pregnancy, High-Risk | 1 | 2014 | 121 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2017 | 587 | 0.030 |
Why?
|
Seasons | 1 | 2019 | 1521 | 0.030 |
Why?
|
Calibration | 1 | 2016 | 814 | 0.030 |
Why?
|
Arteries | 1 | 2018 | 1121 | 0.030 |
Why?
|
Infertility | 1 | 2019 | 655 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2016 | 20129 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2021 | 1217 | 0.030 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2016 | 497 | 0.030 |
Why?
|
Sweden | 1 | 2015 | 1382 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2210 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2019 | 1317 | 0.030 |
Why?
|
Adiposity | 1 | 2022 | 1892 | 0.020 |
Why?
|
Pyrroles | 1 | 2017 | 1120 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2000 | 1884 | 0.020 |
Why?
|
Fetal Monitoring | 1 | 2010 | 69 | 0.020 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2011 | 362 | 0.020 |
Why?
|
Age Factors | 2 | 2019 | 18395 | 0.020 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 267 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2019 | 1662 | 0.020 |
Why?
|
Botswana | 1 | 2013 | 1057 | 0.020 |
Why?
|
Receptors, Cytokine | 1 | 2010 | 258 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6306 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2011 | 3508 | 0.020 |
Why?
|
Observer Variation | 1 | 2016 | 2613 | 0.020 |
Why?
|
Acute-Phase Proteins | 1 | 2010 | 251 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2018 | 14466 | 0.020 |
Why?
|
Sepsis | 1 | 2003 | 2604 | 0.020 |
Why?
|
Metabolomics | 1 | 2018 | 1675 | 0.020 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2010 | 192 | 0.020 |
Why?
|
Adrenal Glands | 1 | 2011 | 556 | 0.020 |
Why?
|
Overweight | 1 | 2020 | 2446 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6259 | 0.020 |
Why?
|
Lipids | 1 | 2019 | 3319 | 0.020 |
Why?
|
Diet, Sodium-Restricted | 1 | 2010 | 291 | 0.020 |
Why?
|
Patient Readmission | 1 | 2022 | 3282 | 0.020 |
Why?
|
Survival Analysis | 1 | 2001 | 10092 | 0.020 |
Why?
|
Aspirin | 1 | 2020 | 3134 | 0.020 |
Why?
|
Catechol O-Methyltransferase | 1 | 2010 | 250 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2014 | 1988 | 0.020 |
Why?
|
Systole | 1 | 2010 | 934 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3885 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2014 | 2108 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2010 | 659 | 0.020 |
Why?
|
Peroxidase | 1 | 2010 | 610 | 0.020 |
Why?
|
Data Collection | 1 | 2016 | 3321 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2920 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2011 | 1732 | 0.020 |
Why?
|
Mice | 3 | 2022 | 81863 | 0.020 |
Why?
|
HIV Infections | 1 | 2013 | 17534 | 0.020 |
Why?
|
Sodium, Dietary | 1 | 2010 | 426 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2019 | 4045 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2012 | 1468 | 0.020 |
Why?
|
Drug Synergism | 1 | 2010 | 1755 | 0.020 |
Why?
|
Developing Countries | 1 | 1998 | 2913 | 0.020 |
Why?
|
Milk, Human | 1 | 2010 | 490 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2227 | 0.020 |
Why?
|
Homeostasis | 1 | 2016 | 3341 | 0.010 |
Why?
|
Sodium | 1 | 2010 | 1593 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2016 | 5302 | 0.010 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2013 | 1899 | 0.010 |
Why?
|
Vesicovaginal Fistula | 1 | 1964 | 10 | 0.010 |
Why?
|
Viral Load | 1 | 2013 | 3385 | 0.010 |
Why?
|
Postpartum Hemorrhage | 1 | 2007 | 275 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2010 | 3093 | 0.010 |
Why?
|
Urinary Bladder Diseases | 1 | 1964 | 166 | 0.010 |
Why?
|
Alleles | 1 | 2014 | 6894 | 0.010 |
Why?
|
Catheterization | 1 | 2007 | 1427 | 0.010 |
Why?
|
Animals | 3 | 2022 | 168887 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8729 | 0.010 |
Why?
|
Clinical Competence | 1 | 2016 | 4858 | 0.010 |
Why?
|
Iatrogenic Disease | 1 | 1964 | 551 | 0.010 |
Why?
|
Liver | 1 | 2016 | 7570 | 0.010 |
Why?
|
Obstetrical Forceps | 1 | 1999 | 9 | 0.010 |
Why?
|
Vacuum Extraction, Obstetrical | 1 | 1999 | 14 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2006 | 2425 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2010 | 3607 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18322 | 0.010 |
Why?
|
Wounds and Injuries | 2 | 1999 | 2513 | 0.010 |
Why?
|
Physicians | 1 | 2016 | 4591 | 0.010 |
Why?
|
Heparin | 1 | 2005 | 1634 | 0.010 |
Why?
|
Labor, Induced | 1 | 1999 | 153 | 0.010 |
Why?
|
Cell Movement | 1 | 2010 | 5197 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11919 | 0.010 |
Why?
|
Immunization Schedule | 1 | 1998 | 229 | 0.010 |
Why?
|
Congenital Abnormalities | 1 | 2001 | 703 | 0.010 |
Why?
|
Venous Thrombosis | 1 | 2005 | 1321 | 0.010 |
Why?
|
Bangladesh | 1 | 1998 | 745 | 0.010 |
Why?
|
Injury Severity Score | 1 | 1999 | 1049 | 0.010 |
Why?
|
Oxytocin | 1 | 1999 | 403 | 0.010 |
Why?
|
Immunization Programs | 1 | 1998 | 267 | 0.010 |
Why?
|
Poverty | 1 | 2006 | 2714 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 18979 | 0.010 |
Why?
|
Brain | 1 | 2020 | 27156 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2016 | 12236 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2006 | 5509 | 0.000 |
Why?
|
Cause of Death | 1 | 1998 | 3714 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 36562 | 0.000 |
Why?
|
Survival Rate | 1 | 1998 | 12825 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1964 | 15818 | 0.000 |
Why?
|